- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02173314
Nevada Initiative to Reduce Long-Term Foster Care
22. marts 2019 opdateret af: Westat
Permanency Innovations Initiative- Nevada Initiative to Reduce Long-Term Foster Care
The evaluation of the Nevada Initiative to Reduce Long-Term Foster Care (LTFC) includes three populations.
It will examine how the interventions SAFE- FC and FSE impact or relate to permanency outcomes for children most at risk for long term foster care and currently in care.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The project targets three populations of children.
For populations 1 and 2, the study will evaluate an intervention known as SAFE-FC.
The intervention aims to prevent long term foster care by providing tailored services and intensive engagement with all new families with children identified as unsafe (Population 1) and for cases that are currently in care and at risk of LTFC where reunification is the case goal (Population 2).
Family Search and Engagement (FSE) is the intervention for Population 3; it involves intense search practices to identify possible permanency resources.
For Populations 1 and 2 the study is a randomized, intent-to-treat design to measure safety and permanency outcomes.
For Population 3 the evaluation will be a descriptive study to analyze relationships between the intervention approach and outcomes.
Both studies aim to examine how the interventions (SAFE- FC and FSE) impact or relate to permanency outcomes for children most at risk for long term foster care.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
507
Fase
- Ikke anvendelig
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
Ikke ældre end 18 år (Barn, Voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Children assessed to be unsafe via the Nevada Initial Assessment
- children in foster care with specific risk characteristics.
Exclusion Criteria:
-
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Behandling
|
SAFE - FC, a combination of SAFE (developed by ACTION for Child Protection) and Family Connections (developed by Ruth H. Young Center for Families and Children, University of Maryland School of Social Work) for Populations 1 and 2.
Andre navne:
|
|
Ingen indgriben: Sammenligning
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Tid til stabil varighed
Tidsramme: Målt fra datoen for tilfældig tildeling til udskrivningsdatoen eller til slutningen af undersøgelsesperioden for sager, der ikke blev udskrevet
|
Målt ved administrative data fra Adoption and Foster Care Analysis and Reporting System (AFCARS)
|
Målt fra datoen for tilfældig tildeling til udskrivningsdatoen eller til slutningen af undersøgelsesperioden for sager, der ikke blev udskrevet
|
|
Caregiver readiness for change
Tidsramme: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
Measured with Readiness for Parenting Change Scale (REDI) Abbreviated (Chaffin et al, 2011)
|
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Caregiver stress
Tidsramme: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
Parenting Stress Index - Short Form (PSI-SF) (Abidin, 1983)
|
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Caregiver mental health
Tidsramme: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
Brief Symptoms Inventory (BSI) (Derogatis, 1993)
|
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
|
Child behavior/mental health problems
Tidsramme: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
Child Behavior Checklist (CBCL) (Achenbach, 1991)
|
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
|
Positive parenting attitudes
Tidsramme: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
Adult-Adolescent Parenting Inventory (AAPI-2) (Bavolek & Keene, 1999)
|
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
|
Social support
Tidsramme: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
Social Provisions Scale (SPS) (Russell & Cutrona, 1984)
|
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
|
Helping alliance for both caregiver and worker
Tidsramme: Measured at 6 months and again at case closure (duration of their involvement with Washoe County DSS is on average 24 months)
|
Helping Relationship Inventory (Poulin & Young, 1997)
|
Measured at 6 months and again at case closure (duration of their involvement with Washoe County DSS is on average 24 months)
|
|
Resiliency
Tidsramme: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
Resiliency Attitudes Scale (RAS) (Briscoe, B. & Harris, B., 1994)
|
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
|
Home stability
Tidsramme: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
Based on subscales of the CWBS (questions from Zuravin & DePanfilis, 1996)
|
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
|
|
Time to permanency
Tidsramme: Measured every six months in calendar year
|
State administrative data system
|
Measured every six months in calendar year
|
|
Recurrence of child abuse and neglect
Tidsramme: Measured every six months in calendar year
|
State administrative data system
|
Measured every six months in calendar year
|
|
Placement rate (population 1 only)
Tidsramme: Measured every six months in calendar year
|
State administrative data system
|
Measured every six months in calendar year
|
|
Time for case closure
Tidsramme: Measured every six months in calendar year
|
State administrative data system
|
Measured every six months in calendar year
|
|
Time to reunification
Tidsramme: Measured every six months in calendar year
|
State administrative data system
|
Measured every six months in calendar year
|
|
Foster care re entry rate
Tidsramme: Measured every six months in calendar year
|
State administrative data system
|
Measured every six months in calendar year
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. september 2010
Primær færdiggørelse (Faktiske)
1. december 2015
Studieafslutning (Faktiske)
1. december 2015
Datoer for studieregistrering
Først indsendt
17. juni 2014
Først indsendt, der opfyldte QC-kriterier
23. juni 2014
Først opslået (Skøn)
24. juni 2014
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
26. marts 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
22. marts 2019
Sidst verificeret
1. marts 2019
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 8977-2
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med I Plejepleje
-
Xuzhou Medical UniversityIkke rekrutterer endnuIkke-invasiv CAR-T-celleovervågning | BCMA-målrettet PET-skanning | CAR-T-cellebiodistribution og -persistens | GMP-overensstemmende Radiopharmaka-præparation
-
The Affiliated Hospital of Xuzhou Medical UniversityRekrutteringCLL | SLL | CAR-T celleterapiKina
-
Duke UniversityNational Institutes of Health (NIH)RekrutteringHæmatopoietisk stamcelletransplantation | CAR-T celleterapiForenede Stater
-
Patrick C. Johnson, MDRekruttering
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRekrutteringPatientrapporterede resultatmål | CAR T-celleterapiSchweiz
-
University Health Network, TorontoIkke rekrutterer endnuLymfom, der modtager CAR-T-terapiCanada
-
The Lymphoma Academic Research OrganisationBristol-Myers Squibb; Novartis; Gilead SciencesRekrutteringHæmatopatologi kvalificeret eller CAR-t-cellebehandlingFrankrig
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T Terapi KomplikationerItalien
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.Ikke rekrutterer endnuAllogen, CAR-T, proteinsekvestrering, ikke-genredigeretKina
-
Shanghai International Medical CenterUkendtAvanceret solid tumor | PD-1 antistof | CAR-T cellerKina
Kliniske forsøg med SAFE FC
-
University of South FloridaAfsluttetDepression | Angst | Søvnmangel | Post traumatisk stress syndrom | Post Intensive Care SyndromeForenede Stater
-
LYSOGENEAfsluttetMucopolysaccharidosis Type III A | Sanfilippo sygdom type AFrankrig
-
LYSOGENEAfsluttetMucopolysaccharidosis Type III A | Sanfilippo sygdom type AFrankrig
-
Shanghai Fosun Pharmaceutical Industrial Development...RekrutteringAvanceret solid tumor | Avanceret kræft | Lungekræft, ikke-småcelletKina
-
VA Office of Research and DevelopmentUniversity of WashingtonIkke rekrutterer endnuIndflydelse af en skråningsadaptiv fod på deltagelse af veteraner med nedre ekstremitetsamputationerAmputationForenede Stater
-
RANDLoyola Marymount UniversityAktiv, ikke rekrutterende
-
Shandong UniversityRekrutteringColitis ulcerosa | Slimhindehealing | Histologisk remission | Fækalt Calprotetin | PASSEKina
-
Biomed Research & Technologies, Inc.AfsluttetAtopisk dermatitisForenede Stater
-
Rabin Medical CenterPulseNmoreRekrutteringKvinder, der gennemgår fertilitetsbehandlingerIsrael
-
Tocagen Inc.AfsluttetGlioblastoma Multiforme | Anaplastisk oligoastrocytom | Anaplastisk astrocytom | Anaplastisk oligodendrogliomForenede Stater